Abstract
In this work we try to shed more light on the critical role of air ventilation, classroom volume, occupancy and face masks (surgical vs ffp2) in airborne transmission risk in schools. The aim is to support a safe school reopening strategy based on quantitative risk assessment, physics of viral aerosol and coupling of different NPIs (non pharmaceutical interventions). Fundamental issues linked to aerosol physics and transmission risk still lack a proper recognition and transposal in school safety regulations. Moreover, most schools are still not provided with mechanical HVAC systems and investigating the risk levels associated to a specific classroom volume becomes critical. The latter issue is furtherly linked to the problem of finding alternative school spaces, especially when the classroom volume is barely sufficient to allow proper social distancing. Therefore fundamental and urgent questions need to be addressed: how the specific classroom volume affects the contagion risk ? is linear social distancing enough to assess a volumetric risk problem? to which extent can we contain a viral aerosol cloud coupling face masks and natural or mechanical ventilation systems? can we further reduce the airborne risk with easy-to-implement countermeasures like lowering the speaking volume or equipping teachers with microphones? To address these fundamental questions we present a theoretical and numerical framework based on the Gammaitoni-Nucci infection risk model, adapted to the SARS-CoV2 case in a real classroom situation. We investigated separately the case of infective asymptomatic student and asymptomatic teacher as viral source, extending a preliminary study by the first author. The critical issue of windows opening during the cold season is also addressed and first recommendations are given to extend the social distancing approach in schools from linear to volumetric.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no external funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
not necessary
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* alessandro.zivelonghi{at}itcspindemonte.edu.it, ing.zivelonghi{at}gmail.com
changed abstract and title
Data Availability
theoretical/computational work based on running python scripts. Python scripts are available upon request